Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Aminobutyrates"" wg kryterium: Temat


Tytuł :
Angiotensin Receptor Neprilysin Inhibitors-2019 Update.
Autorzy :
Chalikias G; Cardiology Department, Medical School, Democritus University of Thrace, Dragana, 68100, Alexandroupolis, Greece.
Tziakas D; Cardiology Department, Medical School, Democritus University of Thrace, Dragana, 68100, Alexandroupolis, Greece. .
Pokaż więcej
Źródło :
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2020 Oct; Vol. 34 (5), pp. 707-722.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Aminobutyrates/*therapeutic use
Angiotensin II Type 1 Receptor Blockers/*therapeutic use
Heart Failure/*drug therapy
Protease Inhibitors/*therapeutic use
Tetrazoles/*therapeutic use
Aminobutyrates/adverse effects ; Aminobutyrates/economics ; Angiotensin II Type 1 Receptor Blockers/adverse effects ; Angiotensin II Type 1 Receptor Blockers/economics ; Cost-Benefit Analysis ; Drug Costs ; Evidence-Based Medicine ; Heart Failure/diagnosis ; Heart Failure/economics ; Heart Failure/physiopathology ; Humans ; Neprilysin/antagonists & inhibitors ; Patient Safety ; Protease Inhibitors/adverse effects ; Protease Inhibitors/economics ; Quality of Life ; Randomized Controlled Trials as Topic ; Recovery of Function ; Risk Assessment ; Risk Factors ; Tetrazoles/adverse effects ; Tetrazoles/economics ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Stable patient with heart failure - the fact or the myth?
Autorzy :
Frączek-Jucha M; 1Jagiellonian University Medical College, Department of Emergency Medical Care, Krakow, Poland; John Paul II Hospital, Department of Coronary Disease and Heart Failure, Krakow, Poland.
Nessler J; 2John Paul II Hospital, Department of Coronary Disease and Heart Failure, Krakow, Poland; Jagiellonian University Medical College, Department of Coronary Disease and Heart Failure, Krakow, Poland.
Pokaż więcej
Źródło :
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego [Pol Merkur Lekarski] 2020 Aug 22; Vol. 49 (286), pp. 245-249.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Aminobutyrates*
Heart Failure*
Angiotensin Receptor Antagonists ; Humans ; Stroke Volume ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Comparative study on the bioactive components and in vitro biological activities of three green seedlings.
Autorzy :
Li X; School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.
Wang P; School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.
Zhu J; School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.
Yi J; School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.
Ji Z; Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China. Electronic address: .
Kang Q; School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.
Hao L; The Quartermaster Research Institute of Engineering and Technology, Academy of Military Sciences PLA China, Beijing 100010, China.
Huang J; School of Agricultural Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.
Lu J; School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China. Electronic address: .
Pokaż więcej
Źródło :
Food chemistry [Food Chem] 2020 Aug 15; Vol. 321, pp. 126716. Date of Electronic Publication: 2020 Mar 30.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Aminobutyrates/*analysis
Coix/*chemistry
Flavonoids/*analysis
Polyphenols/*analysis
Seedlings/*chemistry
Aminobutyrates/pharmacology ; Animals ; Cell Line ; Cell Proliferation/drug effects ; Flavonoids/pharmacology ; Mice ; Plant Extracts/chemistry ; Polyphenols/pharmacology ; Seeds/chemistry
Czasopismo naukowe
Tytuł :
Differential effects of low-dose sacubitril and/or valsartan on renal disease in salt-sensitive hypertension.
Autorzy :
Polina I; Division of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Domondon M; Division of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Fox R; Division of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Sudarikova AV; Division of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.; Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia.
Troncoso M; Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Vasileva VY; Division of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.; Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia.
Kashyrina Y; Division of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Gooz MB; Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina.
Schibalski RS; Division of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
DeLeon-Pennell KY; Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.; Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina.
Fitzgibbon WR; Division of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Ilatovskaya DV; Division of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Pokaż więcej
Źródło :
American journal of physiology. Renal physiology [Am J Physiol Renal Physiol] 2020 Jul 01; Vol. 319 (1), pp. F63-F75. Date of Electronic Publication: 2020 May 28.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Aminobutyrates/*administration & dosage
Angiotensin Receptor Antagonists/*administration & dosage
Blood Pressure/*drug effects
Hypertension/*drug therapy
Kidney Diseases/*drug therapy
Tetrazoles/*administration & dosage
Valsartan/*administration & dosage
Aminobutyrates/therapeutic use ; Angiotensin Receptor Antagonists/therapeutic use ; Animals ; Hypertension/physiopathology ; Kidney Diseases/physiopathology ; Male ; Rats ; Rats, Inbred Dahl ; Sodium Chloride, Dietary ; Tetrazoles/therapeutic use ; Valsartan/therapeutic use
Czasopismo naukowe
Tytuł :
An evaluation of the fixed-dose combination sacubitril/valsartan for the treatment of arterial hypertension.
Autorzy :
Wehland M; Department of Biomedicine, Aarhus University , Aarhus C, Denmark.; Clinic for Plastic, Aesthetic and Hand Surgery, Otto von Guericke University Magdeburg , Magdeburg, Germany.
Simonsen U; Department of Biomedicine, Aarhus University , Aarhus C, Denmark.
Buus NH; Department of Biomedicine, Aarhus University , Aarhus C, Denmark.; Department of Renal Medicine, Aarhus University Hospital , Aarhus, Denmark.
Krüger M; Clinic for Plastic, Aesthetic and Hand Surgery, Otto von Guericke University Magdeburg , Magdeburg, Germany.
Grimm D; Department of Biomedicine, Aarhus University , Aarhus C, Denmark.; Clinic for Plastic, Aesthetic and Hand Surgery, Otto von Guericke University Magdeburg , Magdeburg, Germany.; Department of Microgravity and Translational Regenerative Medicine, Faculty of Medicine and Mechanical Engineering, Otto von Guericke University , Magdeburg, Germany.
Pokaż więcej
Źródło :
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2020 Jul; Vol. 21 (10), pp. 1133-1143. Date of Electronic Publication: 2020 Mar 05.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Aminobutyrates/*therapeutic use
Angiotensin Receptor Antagonists/*therapeutic use
Antihypertensive Agents/*therapeutic use
Hypertension/*drug therapy
Tetrazoles/*therapeutic use
Aminobutyrates/pharmacology ; Angiotensin Receptor Antagonists/pharmacology ; Antihypertensive Agents/pharmacology ; Humans ; Molecular Structure ; Tetrazoles/pharmacology
Czasopismo naukowe
Tytuł :
Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan.
Autorzy :
Januzzi JL Jr; Massachusetts General Hospital, Boston, MA (J.L.J., A.C.).; Detroit Medical Center, MI (I.L.P.).
Camacho A; Massachusetts General Hospital, Boston, MA (J.L.J., A.C.).
Piña IL; Detroit Medical Center, MI (I.L.P.).
Rocha R; Novartis Pharmaceuticals, East Hanover, NJ (R.R., K.M.W., M.F.P.).
Williamson KM; Novartis Pharmaceuticals, East Hanover, NJ (R.R., K.M.W., M.F.P.).
Maisel AS; University of California, San Diego School of Medicine (A.S.M.).
Felker GM; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC (G.M.F.).
Prescott MF; Novartis Pharmaceuticals, East Hanover, NJ (R.R., K.M.W., M.F.P.).
Butler J; University of Mississippi Medical Center, Jackson, MS (J.B.).
Solomon SD; Brigham and Women's Hospital, Boston, MA (S.D.S.).
Pokaż więcej
Corporate Authors :
PROVE-HF Investigators
Źródło :
Circulation. Heart failure [Circ Heart Fail] 2020 Jun; Vol. 13 (6), pp. e006946. Date of Electronic Publication: 2020 Jun 02.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Aminobutyrates/*therapeutic use
Angiotensin II Type 1 Receptor Blockers/*therapeutic use
Heart Failure/*drug therapy
Protease Inhibitors/*therapeutic use
Tetrazoles/*therapeutic use
Ventricular Function, Left/*drug effects
Ventricular Remodeling/*drug effects
Aminobutyrates/adverse effects ; Angiotensin II Type 1 Receptor Blockers/adverse effects ; Disease Progression ; Heart Failure/diagnostic imaging ; Heart Failure/mortality ; Heart Failure/physiopathology ; Hospitalization ; Humans ; Neprilysin/antagonists & inhibitors ; Protease Inhibitors/adverse effects ; Recovery of Function ; Tetrazoles/adverse effects ; Time Factors ; Treatment Outcome
Raport
Tytuł :
[Synthesis of L-2-aminobutyric acid by leucine dehydrogenase coupling with an NADH regeneration system].
Autorzy :
Zhang L; Zhejiang Engineering Research Center of Industrial Biocatalysis and Transformation, Changxing Pharmaceutical Co. Ltd., Changxing 313100, Zhejiang, China.
Xiao Y; Zhejiang Engineering Research Center of Industrial Biocatalysis and Transformation, Changxing Pharmaceutical Co. Ltd., Changxing 313100, Zhejiang, China.
Yang W; Zhejiang Engineering Research Center of Industrial Biocatalysis and Transformation, Changxing Pharmaceutical Co. Ltd., Changxing 313100, Zhejiang, China.
Hua C; Zhejiang Engineering Research Center of Industrial Biocatalysis and Transformation, Changxing Pharmaceutical Co. Ltd., Changxing 313100, Zhejiang, China.
Wang Y; Zhejiang Engineering Research Center of Industrial Biocatalysis and Transformation, Changxing Pharmaceutical Co. Ltd., Changxing 313100, Zhejiang, China.
Li J; Zhejiang Engineering Research Center of Industrial Biocatalysis and Transformation, Changxing Pharmaceutical Co. Ltd., Changxing 313100, Zhejiang, China.
Yang T; School of Biotechnology, Jiangnan University, Wuxi 214122, Jiangsu, China.
Pokaż więcej
Źródło :
Sheng wu gong cheng xue bao = Chinese journal of biotechnology [Sheng Wu Gong Cheng Xue Bao] 2020 May 25; Vol. 36 (5), pp. 992-1001.
Typ publikacji :
Journal Article
MeSH Terms :
Aminobutyrates*/metabolism
Leucine Dehydrogenase*/metabolism
NAD*/metabolism
Escherichia coli/genetics ; Formate Dehydrogenases/metabolism
Czasopismo naukowe
Tytuł :
[Clinical analysis of 15 cases of acute glufosinate poisoning].
Autorzy :
Zhao JB; Department of Emergency, First People's Hospital of Yangquan City, Yangquan 045000, China.
Dong JG; Department of Poisoning Treatment, Fifth Medical Center of the Chinese People's Liberation Army General Hospital, Poisoning Treatment Center of the Army, Beijing 100071, China.
Pokaż więcej
Źródło :
Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases [Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi] 2020 May 20; Vol. 38 (5), pp. 372-374.
Typ publikacji :
Journal Article
MeSH Terms :
Aminobutyrates*/poisoning
Herbicides*/poisoning
Neurotoxicity Syndromes*
Poisoning*/therapy
Respiratory Insufficiency*
Humans
Czasopismo naukowe
Tytuł :
Author's Reply.
Autorzy :
van der Pol S; Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: .
de Jong LA; Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.
Vemer P; Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Jansen DEMC; Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Sociology, Interuniversity Center for Social Science Theory and Methodology (ICS), University of Groningen, Groningen, The Netherlands.
Postma MJ; Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Institute of Science in Healthy Aging and Healthcare, University Medical Center Groningen, University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 May; Vol. 23 (5), pp. 675-676. Date of Electronic Publication: 2020 Mar 18.
Typ publikacji :
Letter; Comment
MeSH Terms :
Aminobutyrates*
Cost-Benefit Analysis ; Germany ; Tetrazoles ; Valsartan
Opinia redakcyjna
Tytuł :
[Production of L-2-aminobutyric acid from L-threonine using a trienzyme cascade].
Autorzy :
Fu Y; State Key Laboratory of Food Science & Technology, Jiangnan University, Wuxi 214122, Jiangsu, China.; School of Biotechnology, Jiangnan University, Wuxi 214122, Jiangsu, China.
Zhang J; State Key Laboratory of Food Science & Technology, Jiangnan University, Wuxi 214122, Jiangsu, China.; School of Biotechnology, Jiangnan University, Wuxi 214122, Jiangsu, China.
Fu X; State Key Laboratory of Food Science & Technology, Jiangnan University, Wuxi 214122, Jiangsu, China.; School of Biotechnology, Jiangnan University, Wuxi 214122, Jiangsu, China.
Xie Y; State Key Laboratory of Food Science & Technology, Jiangnan University, Wuxi 214122, Jiangsu, China.; School of Biotechnology, Jiangnan University, Wuxi 214122, Jiangsu, China.
Ren H; State Key Laboratory of Food Science & Technology, Jiangnan University, Wuxi 214122, Jiangsu, China.; School of Biotechnology, Jiangnan University, Wuxi 214122, Jiangsu, China.
Liu J; State Key Laboratory of Food Science & Technology, Jiangnan University, Wuxi 214122, Jiangsu, China.
Chen X; State Key Laboratory of Food Science & Technology, Jiangnan University, Wuxi 214122, Jiangsu, China.
Liu L; State Key Laboratory of Food Science & Technology, Jiangnan University, Wuxi 214122, Jiangsu, China.; School of Biotechnology, Jiangnan University, Wuxi 214122, Jiangsu, China.; Key Laboratory of Industrial Biotechnology, Ministry of Education, Jiangnan University, Wuxi 214122, Jiangsu, China.
Pokaż więcej
Źródło :
Sheng wu gong cheng xue bao = Chinese journal of biotechnology [Sheng Wu Gong Cheng Xue Bao] 2020 Apr 25; Vol. 36 (4), pp. 782-791.
Typ publikacji :
Journal Article
MeSH Terms :
Aminobutyrates*/chemical synthesis
Formate Dehydrogenases*/metabolism
Leucine Dehydrogenase*/metabolism
Threonine*/metabolism
Threonine Dehydratase*/metabolism
Bacillus thuringiensis/enzymology ; Candida/enzymology ; Escherichia coli/enzymology
Czasopismo naukowe
Tytuł :
Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized With Heart Failure and Reduced Ejection Fraction.
Autorzy :
Fudim M; Duke Clinical Research Institute, Durham, NC (M.F., S.S., A.F.H., A.D.D.).; Division of Cardiology, Duke University Medical Center, Durham, NC (M.F., A.F.H., A.D.D.).
Sayeed S; Duke Clinical Research Institute, Durham, NC (M.F., S.S., A.F.H., A.D.D.).
Xu H; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC (H.X., R.A.M.).
Matsouaka RA; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC (H.X., R.A.M.).
Heidenreich PA; Section of Cardiology, Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA (P.A.H.).
Velazquez EJ; Division of Cardiology, Yale University, New Haven, CT (E.J.V.).
Yancy CW; Division of Cardiology, Northwestern University, Chicago, IL (C.W.Y.).
Fonarow GC; Division of Cardiology, Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles Medical Center (G.C.F.).
Hernandez AF; Duke Clinical Research Institute, Durham, NC (M.F., S.S., A.F.H., A.D.D.).; Division of Cardiology, Duke University Medical Center, Durham, NC (M.F., A.F.H., A.D.D.).
DeVore AD; Duke Clinical Research Institute, Durham, NC (M.F., S.S., A.F.H., A.D.D.).; Division of Cardiology, Duke University Medical Center, Durham, NC (M.F., A.F.H., A.D.D.).
Pokaż więcej
Źródło :
Circulation. Heart failure [Circ Heart Fail] 2020 Apr; Vol. 13 (4), pp. e006645. Date of Electronic Publication: 2020 Apr 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Patient Admission*
Aminobutyrates/*therapeutic use
Angiotensin II Type 1 Receptor Blockers/*therapeutic use
Heart Failure/*drug therapy
Protease Inhibitors/*therapeutic use
Stroke Volume/*drug effects
Tetrazoles/*therapeutic use
Ventricular Function, Left/*drug effects
Aged ; Aged, 80 and over ; Aminobutyrates/adverse effects ; Angiotensin II Type 1 Receptor Blockers/adverse effects ; Biomarkers/blood ; Clinical Decision-Making ; Eligibility Determination ; Evidence-Based Medicine ; Female ; Heart Failure/blood ; Heart Failure/mortality ; Heart Failure/physiopathology ; Humans ; Male ; Middle Aged ; Natriuretic Peptide, Brain/blood ; Neprilysin/antagonists & inhibitors ; Patient Selection ; Peptide Fragments/blood ; Protease Inhibitors/adverse effects ; Randomized Controlled Trials as Topic ; Recovery of Function ; Registries ; Risk Factors ; Tetrazoles/adverse effects ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
LCZ696 and preservation of renal function in heart failure: A meta-analysis of 6 randomized trials.
Autorzy :
Chen X; Department of Cardiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Key Lab of Cardiovascular Disease of Zhejiang Province, Hangzhou, Zhejiang 310009, P. R. China.
Jin C; Department of Cardiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Key Lab of Cardiovascular Disease of Zhejiang Province, Hangzhou, Zhejiang 310009, P. R. China.
Xie L; Department of Cardiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Key Lab of Cardiovascular Disease of Zhejiang Province, Hangzhou, Zhejiang 310009, P. R. China.
Xiang M; Department of Cardiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Key Lab of Cardiovascular Disease of Zhejiang Province, Hangzhou, Zhejiang 310009, P. R. China.
Pokaż więcej
Źródło :
Reviews in cardiovascular medicine [Rev Cardiovasc Med] 2020 Mar 30; Vol. 21 (1), pp. 113-118.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Aminobutyrates/*therapeutic use
Angiotensin II Type 1 Receptor Blockers/*therapeutic use
Heart Failure/*drug therapy
Kidney/*drug effects
Protease Inhibitors/*therapeutic use
Tetrazoles/*therapeutic use
Aged ; Aged, 80 and over ; Aminobutyrates/adverse effects ; Angiotensin II Type 1 Receptor Blockers/adverse effects ; Evidence-Based Medicine ; Female ; Heart Failure/diagnosis ; Heart Failure/physiopathology ; Humans ; Kidney/physiopathology ; Male ; Middle Aged ; Neprilysin/antagonists & inhibitors ; Protease Inhibitors/adverse effects ; Randomized Controlled Trials as Topic ; Risk Factors ; Tetrazoles/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Physiological Factors Affecting Uptake and Translocation of Glufosinate.
Autorzy :
Takano HK; Department of Agricultural Biology, Colorado State University, Fort Collins, Colorado 80523, United States.
Beffa R; Weed Resistance Competence Centre, Bayer AG, Industriepark Hoechst, Frankfurt 65926, Germany.
Preston C; School of Agriculture, Food and Wine, University of Adelaide, Adelaide, South Australia 5005, Australia.
Westra P; Department of Agricultural Biology, Colorado State University, Fort Collins, Colorado 80523, United States.
Dayan FE; Department of Agricultural Biology, Colorado State University, Fort Collins, Colorado 80523, United States.
Pokaż więcej
Źródło :
Journal of agricultural and food chemistry [J Agric Food Chem] 2020 Mar 11; Vol. 68 (10), pp. 3026-3032. Date of Electronic Publication: 2020 Feb 25.
Typ publikacji :
Journal Article
MeSH Terms :
Amaranthus/*metabolism
Aminobutyrates/*metabolism
Herbicides/*metabolism
Amaranthus/chemistry ; Aminobutyrates/chemistry ; Biological Transport ; Herbicides/chemistry ; Kinetics ; Plant Leaves/chemistry ; Plant Leaves/metabolism ; Xylem/chemistry ; Xylem/metabolism
Czasopismo naukowe
Tytuł :
Angiotensin Receptor Neprilysin Inhibitor for Patients With Heart Failure and Reduced Ejection Fraction: Real-World Experience From Taiwan.
Autorzy :
Hsiao FC; Department of Cardiology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan.
Wang CL; Department of Cardiology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan.
Chang PC; Department of Cardiology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan.
Lu YY; Department of Cardiology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan.
Huang CY; Department of Cardiology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan.
Chu PH; Department of Cardiology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
Journal of cardiovascular pharmacology and therapeutics [J Cardiovasc Pharmacol Ther] 2020 Mar; Vol. 25 (2), pp. 152-157. Date of Electronic Publication: 2019 Sep 12.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Aminobutyrates/*therapeutic use
Angiotensin II Type 1 Receptor Blockers/*therapeutic use
Heart Failure/*drug therapy
Neprilysin/*antagonists & inhibitors
Protease Inhibitors/*therapeutic use
Stroke Volume/*drug effects
Tetrazoles/*therapeutic use
Ventricular Function, Left/*drug effects
Adult ; Aged ; Aged, 80 and over ; Aminobutyrates/adverse effects ; Angiotensin II Type 1 Receptor Blockers/adverse effects ; Databases, Factual ; Female ; Health Status ; Heart Failure/diagnosis ; Heart Failure/mortality ; Heart Failure/physiopathology ; Humans ; Male ; Middle Aged ; Protease Inhibitors/adverse effects ; Recovery of Function ; Retrospective Studies ; Risk Factors ; Taiwan ; Tetrazoles/adverse effects ; Time Factors ; Treatment Outcome ; Ventricular Remodeling/drug effects ; Young Adult
Czasopismo naukowe
Tytuł :
In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan.
Autorzy :
Jorba G; Anaxomics Biotech SL, Barcelona, Catalonia, Spain.; Structural Bioinformatics Group, Research Programme on Biomedical Informatics, Department of Experimental and Health Science, Universitat Pompeu Fabra, Barcelona, Catalonia, Spain.
Aguirre-Plans J; Structural Bioinformatics Group, Research Programme on Biomedical Informatics, Department of Experimental and Health Science, Universitat Pompeu Fabra, Barcelona, Catalonia, Spain.
Junet V; Anaxomics Biotech SL, Barcelona, Catalonia, Spain.; Institute of Biotechnology and Biomedicine, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Catalonia, Spain.
Segú-Vergés C; Anaxomics Biotech SL, Barcelona, Catalonia, Spain.
Ruiz JL; Anaxomics Biotech SL, Barcelona, Catalonia, Spain.
Pujol A; Anaxomics Biotech SL, Barcelona, Catalonia, Spain.
Fernández-Fuentes N; Department of Biosciences, U Science Tech, Universitat de Vic-Universitat Central de Catalunya, Vic, Catalonia, Spain.
Mas JM; Anaxomics Biotech SL, Barcelona, Catalonia, Spain.
Oliva B; Structural Bioinformatics Group, Research Programme on Biomedical Informatics, Department of Experimental and Health Science, Universitat Pompeu Fabra, Barcelona, Catalonia, Spain.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Feb 13; Vol. 15 (2), pp. e0228926. Date of Electronic Publication: 2020 Feb 13 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Aminobutyrates/*pharmacology
Systems Biology/*methods
Tetrazoles/*pharmacology
Valsartan/*pharmacology
Aminobutyrates/adverse effects ; Angiotensin Receptor Antagonists/therapeutic use ; Biomarkers ; Computer Simulation ; Heart/drug effects ; Heart Failure/diagnosis ; Humans ; Neprilysin/pharmacology ; Software ; Stroke Volume/physiology ; Tetrazoles/adverse effects ; Valsartan/adverse effects ; Ventricular Function, Left/physiology
Czasopismo naukowe
Tytuł :
Substance and Substrate: LVEF and Sex Subgroup Analyses of PARAGON-HF and PARADIGM-HF Trials.
Autorzy :
Bozkurt B; Baylor College of Medicine, DeBakey VA Medical Center, Winters Center for Heart Failure Research, Cardiovascular Research Institute, Houston, TX (B.B.).
Ezekowitz J; Department of Medicine, Division of Cardiology, Katz Group Centre for Pharmacy and Health Research, University of Alberta, Canada (J.E.).
Pokaż więcej
Źródło :
Circulation [Circulation] 2020 Feb 04; Vol. 141 (5), pp. 362-366. Date of Electronic Publication: 2020 Feb 03.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Aminobutyrates*
Heart Failure*
Female ; Humans ; Male ; Tetrazoles ; Valsartan
Opinia redakcyjna
Tytuł :
Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.
Autorzy :
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, UK (J.J.V.M., A.M.J., P.S.J.).
Jackson AM; BHF Cardiovascular Research Centre, University of Glasgow, UK (J.J.V.M., A.M.J., P.S.J.).
Lam CSP; National Heart Center Singapore and Duke-National University of Singapore (C.S.P.L.).; Department of Cardiology, University Medical Center Groningen, University of Groningen, The Netherlands (C.S.P.L., D.J.v.V.).; The George Institute for Global Health, Newtown, Australia (C.S.P.L.).
Redfield MM; Mayo Clinic, Rochester, MN (M.M.R.).
Anand IS; University of Minnesota, Minneapolis (I.S.A.).
Ge J; Shanghai Institute of Cardiovascular Diseases, China (J.G.).
Lefkowitz MP; Novartis Pharmaceuticals, East Hanover, NJ (M.P.L., A.R.R., S.V.S., V.C.S.).
Maggioni AP; National Association of Hospital Cardiologists Research Center, Florence, Italy (A.P.M.).
Martinez F; National University of Cordoba, Argentina (F.M.).
Packer M; Baylor University Medical Center, Dallas, TX (M.P.).
Pfeffer MA; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.A.P., A.M.S., B.C., S.D.S.).
Pieske B; Department of Internal Medicine and Cardiology, German Center for Cardiovascular Research Partner Site Berlin, Germany (B.P.).
Rizkala AR; Novartis Pharmaceuticals, East Hanover, NJ (M.P.L., A.R.R., S.V.S., V.C.S.).
Sabarwal SV; Novartis Pharmaceuticals, East Hanover, NJ (M.P.L., A.R.R., S.V.S., V.C.S.).
Shah AM; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.A.P., A.M.S., B.C., S.D.S.).
Shah SJ; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (S.J.S.).
Shi VC; Novartis Pharmaceuticals, East Hanover, NJ (M.P.L., A.R.R., S.V.S., V.C.S.).
van Veldhuisen DJ; Department of Cardiology, University Medical Center Groningen, University of Groningen, The Netherlands (C.S.P.L., D.J.v.V.).
Zannad F; INSERM Centre d'Investigation Clinic 1433 and Universite de Lorraine, Centre Hospitalier Regional et Universitaire, Nancy, France (F.Z.).
Zile MR; Medical University of South Carolina and the Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston (M.R.Z.).
Cikes M; Department of Cardiovascular Diseases, University of Zagreb School of Medicine and University Hospital Centre Zagreb, Croatia (M.C.).
Goncalvesova E; Department of Heart Failure-Transplantation, National Cardiovascular Institute, Bratislava, Slovakia (E.G.).
Katova T; Clinic of Cardiology, National Cardiology Hospital, Sofia, Bulgaria (T.K.).
Kosztin A; Heart and Vascular Center, Semmelweis University, Budapest, Hungary (A.K.).
Lelonek M; Department of Noninvasive Cardiology, Medical University of Lodz, Poland (M.L.).
Sweitzer N; University of Arizona Sarver Heart, Tucson (N.S.).
Vardeny O; Minneapolis VA Center for Care Delivery and Outcomes Research, University of Minnesota (O.V.).
Claggett B; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.A.P., A.M.S., B.C., S.D.S.).
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, UK (J.J.V.M., A.M.J., P.S.J.).
Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.A.P., A.M.S., B.C., S.D.S.).
Pokaż więcej
Źródło :
Circulation [Circulation] 2020 Feb 04; Vol. 141 (5), pp. 338-351. Date of Electronic Publication: 2019 Nov 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Sex Factors*
Aminobutyrates/*pharmacology
Heart Failure/*drug therapy
Tetrazoles/*pharmacology
Valsartan/*therapeutic use
Aged ; Aged, 80 and over ; Aminobutyrates/adverse effects ; Angiotensin Receptor Antagonists/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Female ; Heart Failure/physiopathology ; Humans ; Male ; Middle Aged ; Stroke Volume/drug effects ; Tetrazoles/adverse effects ; Valsartan/adverse effects
Czasopismo naukowe
Tytuł :
Sacubitril-Valsartan for the Treatment of Heart Failure: Time for a Paragon?
Autorzy :
Del Buono MG; Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Pauley Heart Center, Richmond, VA.; Department of Cardiovascular and Thoracic Sciences, Catholic University of the Sacred Heart, Rome, Italy.
Bonaventura A; Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Pauley Heart Center, Richmond, VA.; Department of Internal Medicine, First Clinic of Internal Medicine, University of Genoa, Genoa, Italy.
Vecchié A; Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Pauley Heart Center, Richmond, VA.; Department of Internal Medicine, First Clinic of Internal Medicine, University of Genoa, Genoa, Italy.
Wohlford GF; Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University, Richmond, VA.
Dixon DL; Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University, Richmond, VA.
Van Tassel BW; Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University, Richmond, VA.
Abbate A; Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Pauley Heart Center, Richmond, VA.
Pokaż więcej
Źródło :
Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2020 Feb; Vol. 75 (2), pp. 105-107.
Typ publikacji :
Editorial
MeSH Terms :
Aminobutyrates/*therapeutic use
Angiotensin II Type 1 Receptor Blockers/*therapeutic use
Heart Failure/*drug therapy
Protease Inhibitors/*therapeutic use
Tetrazoles/*therapeutic use
Aminobutyrates/adverse effects ; Angiotensin II Type 1 Receptor Blockers/adverse effects ; Clinical Trials as Topic ; Comorbidity ; Heart Failure/diagnosis ; Heart Failure/mortality ; Heart Failure/physiopathology ; Humans ; Neprilysin/antagonists & inhibitors ; Protease Inhibitors/adverse effects ; Recovery of Function ; Risk Factors ; Tetrazoles/adverse effects ; Treatment Outcome
Opinia redakcyjna
Tytuł :
The art of caring for adults with congenital heart disease in the face of imperfect data.
Autorzy :
Menachem JN; Department of Cardiology, Vanderbilt University Medical Center, Nashville, TN, United States of America. Electronic address: .
Opotowsky AR; Department of Cardiology, Boston Children's Hospital, Boston, MA, United States of America; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America. Electronic address: .
Pokaż więcej
Źródło :
International journal of cardiology [Int J Cardiol] 2020 Feb 01; Vol. 300, pp. 141-142. Date of Electronic Publication: 2019 Aug 02.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Aminobutyrates*
Heart Failure*
Adult ; Humans ; Tetrazoles ; Valsartan
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies